AI-based drug developer Basecamp valued at $800 million after $140 million funding round

T1Covered by 1 source · first reported by Economic Times — Tech / Technology / Startups / ETTelecom at 23 Sept, 13:12 UTC

The oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.

aibusinesshardwareindia

Sources

• T1AI-based drug developer Basecamp valued at $800 million after $140 million funding roundEconomic Times — Tech / Technology / Startups / ETTelecom23 Sept, 13:12